Artemis Medicare Services Limited Share Price Bombay S.E.

Equities

ARTEMISMED

INE025R01021

Healthcare Facilities & Services

Market Closed - Bombay S.E. 03:30:50 26/04/2024 pm IST 5-day change 1st Jan Change
184.8 INR +1.12% Intraday chart for Artemis Medicare Services Limited +3.56% +2.70%
Sales 2024 * 9.84B 118M Sales 2025 * 13.69B 164M Capitalization 25.32B 304M
Net income 2024 * 620M 7.44M Net income 2025 * 800M 9.6M EV / Sales 2024 * 2.57 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.85 x
P/E ratio 2024 *
40.2 x
P/E ratio 2025 *
30.8 x
Employees 1,937
Yield 2024 *
-
Yield 2025 *
-
Free-Float 22.11%
More Fundamentals * Assessed data
Dynamic Chart
IFC to Invest INR3.30 Billion in Artemis Medicare Services MT
Artemis Medicare Services Limited announced that it expects to receive INR 3.3 billion in funding from International Finance Corporation CI
Artemis Medicare Services Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Artemis Medicare Services Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Artemis Medicare Services Posts Gains in Fiscal Q1 Consolidated Net Profit MT
Artemis Medicare Services Limited Announces Capacity Addition CI
Artemis Medicare Services Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Artemis Medicare Services Limited Approves Dividend for the Financial Year Ended March 31, 2023 CI
Artemis Medicare Services Limited Proposes Final Dividend or the Financial Year Ended March 31, 2023 CI
Artemis Medicare Services Opens New Center in Gurugram, India MT
Artemis Medicare Services Limited Announces Opening of New Centre At Sector-82, Gurugram Under 'Artemis Lite' Brand CI
Artemis Medicare Services' Consolidated Profit Slides in Fiscal Q4 MT
Artemis Medicare Services Limited Recommends Final Dividend for 2023 CI
Artemis Medicare Services Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Artemis Medicare Services Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
More news
1 day+1.12%
1 week+3.56%
Current month+8.80%
1 month+7.38%
3 months+1.12%
6 months+24.92%
Current year+2.70%
More quotes
1 week
180.60
Extreme 180.6
188.10
1 month
169.25
Extreme 169.25
195.55
Current year
140.60
Extreme 140.6
195.55
1 year
73.75
Extreme 73.75
195.55
3 years
18.57
Extreme 18.565
195.55
5 years
12.00
Extreme 12
195.55
10 years
12.00
Extreme 12
195.55
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/07/01
Director of Finance/CFO - -
Compliance Officer - 09/22/09
Members of the board TitleAgeSince
Director/Board Member 52 17/08/17
Director/Board Member 80 19/06/19
Director/Board Member 56 17/07/17
More insiders
Date Price Change Volume
26/24/26 184.8 +1.12% 5,719
25/24/25 182.7 -0.16% 2,619
24/24/24 183 +0.41% 1,127
23/24/23 182.2 -0.05% 6,874
22/24/22 182.4 +2.21% 6,274

Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST

More quotes
Artemis Medicare Services Ltd, also known as Artemis Hospitals, is an India-based company, which operates a multi-specialty hospital. The Company is specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (haematology), bones, muscles and joints (orthopaedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and metabolismheart (cardiology), infectious diseases, kidneys (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynaecology, psychiatry, rheumatology (arthritis and joint disease), surgery and urology. The Company's subsidiary includes Artemis Cardiac Care Private Limited.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
184.9 INR
Average target price
229 INR
Spread / Average Target
+23.85%
Consensus

Annual profits - Rate of surprise